Greater Manchester and East Cheshire residents experiencing Covid-19 symptoms are being urged to take part in a national priority clinical trial to identify medicines that can help people recover from the virus at home.

The PRINCIPLE trial is investigating treatments for early-stage Covid-19 that can reduce overall recovery time and the severity of symptoms – and prevent the need for hospital admission.

PRINCIPLE is led by the University of Oxford and supported by the National Institute for Health Research.

Since launching in March 2020, PRINCIPLE has recruited more than 4,400 participants from across the UK – including more than 180 from Greater Manchester and East Cheshire. As part of the trial, several commonly-used medicines with well-known safety profiles are being evaluated and compared with usual NHS care.

Now, the trial is evaluating the effectiveness of the gout drug colchicine, and has expanded to include adults of any age.

Previously, only those with Covid-19 aged 50 or over and at most risk of complications from the illness were eligible to join the PRINCIPLE trial. For the colchicine arm, the trial now includes participants either aged 18-64 with shortness of breath from the illness or certain underlying health conditions that put them at risk of severe illness, or those aged over 65. Participants are only eligible to join the trial during the first 14 days of Covid-19 illness.

Colchicine is an inexpensive anti-inflammatory drug widely used in the UK for many years as a treatment for acute gout. In Canada’s ColCorona trial, the drug has recently shown promise in reducing hospital admissions in patients with Covid-19, yet little is known about its effectiveness in reducing recovery time or the burden of the illness.

With the UK’s vaccine programme continuing at pace in vulnerable adults, and the remaining urgent need for evidence-based treatments that help people recover at home, expanding parts of the trial to people aged under 50 will provide new insights into whether treatments can help those at greater risk of severe Covid-19 illness.

NHS Researchers in Greater Manchester are today renewing their call for eligible adults with early Covid-19 symptoms to consider joining the trial – with sign-up available online or by telephone.

Andrew Gwynne said:

“The public conversation has moved on to the vaccine roll-out and restrictions lifting, but it’s important to remember that Covid is still around and people are still getting very ill.

 

“This trial is trying to find a treatment for those with Covid-19 to help them recover at home and take the strain off our NHS.

 

“If you’re experiencing Covid symptoms, I’d encourage you to find out if you can get involved in this trial. As with the vaccine, we are relying on volunteers to help us find out how to beat this terrible virus.”

Dr Sheila McCorkindale, Specialty Lead for Primary Care at NIHR Clinical Research Network Greater Manchester, said:

“Clinical research is one of the NHS’ greatest assets in the fight against Covid-19 and has already helped identify safe and effective vaccines and medications that are helping reduce the risk of death in the sickest patients hospitalised with the virus.

 

“However, it’s also crucial that we determine which treatments can help people experiencing milder Covid-19 symptoms, so they can get better at home and not need hospital treatment. The PRINCIPLE trial is the way we can do this, and I urge anyone who develops symptoms to take a look at the website or ask their GP or other healthcare provider about this study.

 

“The criteria for taking part is now much wider – meaning any adult with symptoms could potentially be part of this urgent research.”

To find out more about how to join the study, visit www.principletrial.org or call 0800 138 0880.

Constituency Office Address

Town Hall, Market Street, Denton, M34 2AP

Parliamentary Office Address

House of Commons, London, SW1A 0AA

Newsletter